×

Evolution of the activist investor

10:12 AM ET Tue, 22 April 2014

CNBC's David Faber speaks with Keith Meister, Corvex Management managing partner, about the role and engagement of the activist investor and shares his thoughts on Valeant Pharmaceuticals bid for Allergan.